Efg Asset Management (North America) Corp. Neurocrine Biosciences Inc Transaction History
Efg Asset Management (North America) Corp.
- $705 Million
- Q4 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 13,321 shares of NBIX stock, worth $1.36 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
13,321
Previous 27,511
51.58%
Holding current value
$1.36 Million
Previous $3.17 Million
42.6%
% of portfolio
0.26%
Previous 0.54%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
652Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.03 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$498 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$307 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$258 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.73B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...